AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 144 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,670 | -28.0% | 16,829 | -38.1% | 0.00% | – |
| Q2 2023 | $24,539 | +5.7% | 27,199 | -34.3% | 0.00% | – |
| Q1 2023 | $23,209 | -41.0% | 41,415 | -39.2% | 0.00% | – |
| Q4 2022 | $39,313 | +78.7% | 68,133 | 0.0% | 0.00% | – |
| Q3 2022 | $22,000 | +46.7% | 68,133 | +59.2% | 0.00% | – |
| Q2 2022 | $15,000 | -6.2% | 42,792 | +95.7% | 0.00% | – |
| Q1 2022 | $16,000 | -66.7% | 21,863 | +2.7% | 0.00% | – |
| Q4 2021 | $48,000 | -7.7% | 21,280 | +2.3% | 0.00% | – |
| Q3 2020 | $52,000 | -93.0% | 20,800 | -61.7% | 0.00% | -100.0% |
| Q2 2020 | $738,000 | -4.2% | 54,334 | -46.5% | 0.00% | 0.0% |
| Q1 2020 | $770,000 | +234.8% | 101,622 | +179.0% | 0.00% | +100.0% |
| Q4 2019 | $230,000 | – | 36,420 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |